TUPPERWARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Tupperware Brands Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 29, 2024 02:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Tupperware Brands...
Hormone Replacement Therapy Market Surges, to Reach USD 50.5 Billion by 2033 with a 7.8% CAGR
January 29, 2024 01:56 ET
|
MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The hormone replacement therapy was valued at USD 24.3 billion in 2023 with significant growth and is projected to reach at USD 50.5 billion by 2033 with...
Pharmaceutical Software Market is set to Reach US$ 5.69 billion at a CAGR of 8.45% from the forecast period 2023 to 2031 | Growth Plus Reports
January 29, 2024 01:48 ET
|
Growth Plus Reports
Pune, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Pharmaceutical Software Market is expected to clock US$ 5.69 billion by 2031 and...
KUTSU OmaSp:n vuoden 2023 tilinpäätöstiedotteen tiedotustilaisuuteen 5.2.2024
January 29, 2024 01:40 ET
|
Oma Säästöpankki Oyj
OMA SÄÄSTÖPANKKI OYJ, SIJOITTAJAUUTINEN 29.1.2024 KUTSU OmaSp:n vuoden 2023 tilinpäätöstiedotteen tiedotustilaisuuteen 5.2.2024 Oma Säästöpankki Oyj (OmaSp) julkaisee vuoden 2023...
BGHL (EUR): NAV(s)
January 29, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
BGHL (GBP): NAV(s)
January 29, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Stockwik appoints Urban Lindskog as CEO
January 29, 2024 01:30 ET
|
Stockwik Förvaltning AB
The Stockwik Board of Directors today decided to appoint Urban Lindskog as the CEO of the company. Urban Lindskog brings with him extensive experience from leading positions and board assignments in...
ARMGO Pharma Publishes Positive Phase 1b Trial Results of Rycal® ARM210 for the Treatment of Ryanodine Receptor 1 Related Myopathies
January 29, 2024 01:00 ET
|
ARMGO
ARMGO Pharma Publishes Positive Phase 1b Trial Results of Rycal® ARM210 for the Treatment of Ryanodine Receptor 1 Related Myopathies Phase 1b open label trial confirms safety and tolerability of 120...
Philips delivers strong full-year results; agrees with FDA on terms of consent decree focused on Philips Respironics in the US
January 29, 2024 01:00 ET
|
Royal Philips
January 29, 2024 Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 planAgrees with FDA...
Sequana Medical announces FDA acceptance for substantive review of the Premarket Approval application for alfapump® in recurrent or refractory ascites due to liver cirrhosis
January 29, 2024 01:00 ET
|
Sequana Medical NV
PRESS RELEASE Acceptance and filing review is a first step in the PMA review process Indicates PMA application is sufficiently complete for in-depth review Received in advance of anticipated...
- August 14, 2024 17:35 ET United States Mint 2023 American Liberty High Relief Gold Coin™ Takes Top Honors in 2024 COTY Awards
- August 14, 2024 16:50 ET The Law Office of Joel M. Vecchio Launches New Website